Lupin Strikes Deal For Anti-TB Drug Pretomanid

Company Plans To Commercialize Highly-Drug Resistant TB Medicine In 140 Countries

 
• By Akriti Seth
  
TB tuberculosis lung 3D x-ray
Lupin has entered into a partnership for new Therapy for Highly Drug-Resistant TB • Source: Alamy

More from Deals

More from Business